CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,275 | -72.3% | 119 | -65.9% | 0.00% | – |
| Q2 2023 | $11,842 | -18.9% | 349 | -14.0% | 0.00% | – |
| Q1 2023 | $14,608 | -19.3% | 406 | 0.0% | 0.00% | – |
| Q4 2022 | $18,095 | +64.5% | 406 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | 0.0% | 406 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 406 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 406 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -27.3% | 406 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +57.1% | 406 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | +75.0% | 406 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 406 | +14.0% | 0.00% | – |
| Q4 2020 | $6,000 | – | 356 | +5833.3% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |